Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine with Chemo/Radiation in Limited Stage Small-Cell Lung Cancer
NCT00003583Phase 2Unknown
- Sponsor
- University of Florida
- Start
- Jun 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in acute radiation syndrome (ARS), chemotherapy-induced toxicity, sponsored by University of Florida. Status: unknown.
02
Drugs
amifostine
03
Conditions
acute radiation syndrome (ARS)chemotherapy-induced toxicity
Beyond the preview
Go deeper on NCT00003583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003583.